The agenda features a mix of clinical updates and lively debates on provocative scientific topics impacting the field, including emerging concepts and therapies in breast and gynecological cancers.



Clinical Topics in Breast Cancer

Chaired by Erika P. Hamilton, MD

HER2-Positive Breast Cancer: HER2 Expression and Targeted Therapy in Early Breast Cancer
HR-Positive Breast Cancer: Stratification Risk and Selecting Therapy
CDK4/6 Inhibitors Across Early and Metastatic Breast Cancer
HER2-Positive Metastatic Breast Cancer: Where are We Headed?
Immunotherapy for Breast Cancer: Patient Selection and Data
Beyond Immunotherapy: Novel Agents in TNBC
Biosimilars in Breast Cancer Therapy

Clinical Topics in Gynecological Cancers

Chaired by Kathleen N. Moore, MD, MS

Changing Treatment Paradigms for Ovarian and Cervical Cancers
Current and Emerging Targets in Platinum-Resistant Ovarian Cancer Treatment
Therapeutic Strategies for Cervical Malignancies
First- and Second-Line Therapies in Endometrial Cancer
Precision and Personalized Medicine in Gynecological Cancers
Testing and Biomarkers

Special Topics in Breast and Gynecological Cancers

Care of Special Populations
Endocrine Therapies
Refining Risk Stratification and Treatment Escalation